Obesity and Risk for Incomplete Stone Clearance in Patients with Bile Duct Stones Undergoing ERCP.

Choledocholithiasis Endoscopic retrograde cholangiopancreatography Obesity

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
14 Dec 2023
Historique:
received: 09 07 2023
accepted: 06 12 2023
revised: 20 11 2023
medline: 14 12 2023
pubmed: 14 12 2023
entrez: 13 12 2023
Statut: aheadofprint

Résumé

Obesity degrades fluoroscopic image quality and could impact on the endoscopic retrograde cholangiopancreatography (ERCP) outcomes. Our study aimed to compare the clinical outcomes and adverse events (AEs) between obese and non-obese patients undergoing ERCP for biliary stone-related conditions. Patients who underwent ERCP for biliary-stone related conditions were included. The analyzed outcomes included the rates of successful bile duct cannulation, incomplete bile duct stone clearance, recurrent bile duct stones, and AEs. A total of 229 patients (116 obese patients and 113 non-obese patients) were included. All patients had successful bile duct cannulation. The rates of incomplete bile duct stone clearance (11.3% vs. 9.0%, P = 0.51), recurrent bile duct stones (1.9% vs. 4.2%, P = 0.24), and AEs (1.8% vs. 0.7%, P = 0.43) were not significantly different between the two groups, respectively. Our study demonstrates no associations between obesity and the rates of incomplete stone clearance, recurrent stones, successful cannulation, or AEs in patients undergoing ERCP for biliary stone-related disease.

Identifiants

pubmed: 38093022
doi: 10.1007/s11695-023-06983-8
pii: 10.1007/s11695-023-06983-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. https://doi.org/10.1038/nrdp.2016.24 .
doi: 10.1038/nrdp.2016.24 pubmed: 27121416
Frybova B, Drabek J, Lochmannova J, et al. Cholelithiasis and choledocholithiasis in children; risk factors for development. PLoS One. 2018;13(5):e0196475. https://doi.org/10.1371/journal.pone.0196475 .
doi: 10.1371/journal.pone.0196475 pubmed: 29763444 pmcid: 5953441
Oh CH, Dong SH, Kim J-W, et al. Radiation exposure during endoscopic retrograde cholangiopancreatography according to clinical determinants. Medicine. 2020;99(13):e19498. https://doi.org/10.1097/MD.0000000000019498 .
doi: 10.1097/MD.0000000000019498 pubmed: 32221072 pmcid: 7220418
Aberle D, Charles H, Hodak S, et al. Optimizing care for the obese patient in interventional radiology. Diagn Interv Radiol (Ankara, Turkey). 2017;23(2):156–62. https://doi.org/10.5152/dir.2016.16230 .
doi: 10.5152/dir.2016.16230
Fujisawa T, Kagawa K, Hisatomi K, et al. Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol. 2016;51(9):931–8. https://doi.org/10.1007/s00535-016-1160-x .
doi: 10.1007/s00535-016-1160-x pubmed: 26792788
Chen B, Yo C-H, Patel R, et al. Morbid obesity but not obesity is associated with increased mortality in patients undergoing endoscopic retrograde cholangiopancreatography: a National Cohort Study. United European Gastroenterol J. 2021;9(5):561–70. https://doi.org/10.1002/ueg2.12070 .
doi: 10.1002/ueg2.12070 pubmed: 33951338 pmcid: 8259364
Kilic ET, Sayar S, Kahraman R, et al. The effects of obesity on sedation-related outcomes of advanced endoscopic procedures. Northern Clin Istanbul. 2019;6(4):321–6. https://doi.org/10.14744/nci.2019.93763 .
doi: 10.14744/nci.2019.93763
Abdelfatah MM, Koutlas NJ, Gochanour E, et al. Impact of body mass index on the incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis. Ann Gastroenterol. 2019;32(3):298–302. https://doi.org/10.20524/aog.2019.0367 .
doi: 10.20524/aog.2019.0367 pubmed: 31040628 pmcid: 6479648
Deenadayalu VP, Blaut U, Watkins JL, et al. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study. J Clin Gastroenterol. 2008;42(10):1103–9. https://doi.org/10.1097/MCG.0b013e318159cbd1 .
doi: 10.1097/MCG.0b013e318159cbd1 pubmed: 18936645

Auteurs

Veeravich Jaruvongvanich (V)

Division of Gastroenterology, Queen's Health System, Honolulu, HI, USA.

Vishal Garimella (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Jyotroop Kaur (J)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Vinay Chandrasekhara (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Chandrasekhara.vinay@mayo.edu.

Classifications MeSH